Status:
RECRUITING
Cohort of IPF Patients Experiencing an Exacerbation
Lead Sponsor:
University Hospital, Gentofte, Copenhagen
Conditions:
Idiopathic Pulmonary Fibrosis
Eligibility:
All Genders
18+ years
Brief Summary
Extension of the PFBIO cohort which includes patients with newly diagnosed idiopathic pulmonary fibrosis (IPF) for longitudinal follow-up for up to 5 years. In the PFBIO-EXA extension, patients are i...
Detailed Description
The aim of this study is to investigate the diagnostic and prognostic value of clinical and blood biomarkers during exacerbations, or other increase in respiratory symptoms requiring hospital admissio...
Eligibility Criteria
Inclusion
- Admitted with an increase in respiratory symptoms
- Already included in PFBIO or included simultaneously in PFBIO and PFBIO-EXA
- Age at least 18 years
Exclusion
- Unable to provide informed consent
Key Trial Info
Start Date :
June 13 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04442711
Start Date
June 13 2020
End Date
December 31 2028
Last Update
December 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Herlev and Gentofte Hospital
Hellerup, Copenhagen, Denmark, 2900